Clinical Trial Update: Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating ZG005 in combination with Gecacitinib and chemotherapy for advanced solid tumors; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Chemotherapy (chemotherapy)
• Gecacitinib (Gecacitinib)
• ZG005

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING